Kathleen M. Rupprecht

Author

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

K M Rupprecht, K. M. RUPPRECHT, K. M. Rupprecht, Kathleen M. Rupprecht, Kathleen Rupprecht

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Massachusetts Institute of Technology Harvard University

About

Kathleen M. Rupprecht is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	15	2.4K
2	Natural Sciences	9	9	588
3	Biochemistry	9	9	564
4	Social Sciences	2	2	42
5	Allergy	1	1	1.7K

Kathleen M. Rupprecht

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Alteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists Suzanne Mandala, Richard Hajdu, James D. Bergstrom, Science Lymphocyte DevelopmentImmunologyImmunologic MechanismImmunotherapyLymphoid Sinuses	2002	1.7K
Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Nahum Sonenberg, Kathleen M. Rupprecht, Sidney M. Hecht, Proceedings of the National Academy of Sciences Viral ReplicationEukaryotic Mrna CapMolecular BiologyViral Structural ProteinVirus Structure	1979	263
Identification and Biochemical Characterization of a Novel Nortriterpene Inhibitor of the Human Lymphocyte Voltage-Gated Potassium Channel, Kv1.3 John P. Felix, Randal M. Bugianesi, William A. Schmalhofer, Biochemistry Chemical BiologyExperimental PharmacologyPotassium Channel StructureNovel Nortriterpene InhibitorMolecular Pharmacology	1999	95
Correolide and Derivatives Are Novel Immunosuppressants Blocking the Lymphocyte Kv1.3 Potassium Channels Gloria C. Koo, Joseph T. Blake, Kashmira Shah, Cellular Immunology InflammationMolecular PhysiologyHyperpolarization (Biology)MedicineImmunosuppressive Therapy	1999	81
Identification of a New Class of Inhibitors of the Voltage-Gated Potassium Channel, K<sub>v</sub>1.3, with Immunosuppressant Properties William A. Schmalhofer, Jianming Bao, Owen B. McManus, Biochemistry ImmunologyPharmacotherapyExperimental PharmacologyMolecular PharmacologyMedicinal Chemistry	2002	64
The medicinal chemistry of FK-506 Mark T. Goulet, Kathleen M. Rupprecht, Peter M. Sinclair, Perspectives in Drug Discovery and Design Medicinal ChemistryPharmaceutical ScienceBioorganic ChemistryBiochemistryNatural Sciences	1994	38
Controlling the stereochemistry of the ring junction in hexahydrodibenzofurans Kathleen M. Rupprecht, Joshua Boger, Karst Hoogsteen, The Journal of Organic Chemistry AltmetricsMolecular SciencesHeterocyclicDonut IconNatural Sciences	1991	35
Synthesis of L-erythro-.beta.-hydroxyhistidine from D-glucosamine Sidney M. Hecht, Kathleen M. Rupprecht, Paula Jacobs Journal of the American Chemical Society Pharmaceutical ScienceNatural Product SynthesisBioorganic ChemistryBiochemistryDonut Icon	1979	33
Dominant Mutations Confer Resistance to the Immunosuppressant, Rapamycin, in Variants of a T Cell Lymphoma Francis J. Dumont, Mary Jo Staruch, Timothy C. Grammer, Cellular Immunology Lymphoid NeoplasiaImmunodeficienciesImmunologyPathologyResistance Mutation (Virology)	1995	33
Synthesis of the lipophilic side chain of the cyclic hexadepsipeptide antibiotic L-156,602 Charles G. Caldwell, Kathleen M. Rupprecht, Steven Bondy, The Journal of Organic Chemistry Pharmaceutical ScienceBioorganic ChemistryAltmetric Attention ScoreAntimicrobial ChemotherapyPharmaceutical Chemistry	1990	32

Page 1